5 More serious GI adverse events have been reported with GLP-1 RAs too, which increase the risk of pancreatitis, bowel obstruction, and gastroparesis
Our understanding of the long-term safety of GLP-1 agonists remains limited, a concern that is particularly pertinent for chronic conditions such as pain and headaches
The disadvantage is that it can cause vomiting
First, we only included eight subjects (7 female, 1 male) in this explorative pilot study which limits the full interpretation of the data
Diabetes 65 (1), 172187
These next-generation agents engage not only GLP-1 receptors but also those for other gastro-entero-pancreatic hormones such as glucose-dependent insulinotropic polypeptide (GIP), glucagon, amylin, and peptide YY to enhance energy uptake, storage, and expenditure through synergistic mechanisms